Zymeworks Inc. Revenue 2020–2025
Zymeworks Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Zymeworks Inc. revenue for the quarter ending March 31, 2026 was 2.4 M, a 91.12% decrease year-over-year.
- Zymeworks Inc. revenue for the twelve months ending March 31, 2026 was 105.9 M, a 71.35% increase year-over-year.
- Zymeworks Inc. annual revenue for 2025 was 106.0 M, a 38.87% increase from 2024.
- Zymeworks Inc. annual revenue for 2024 was 76.3 M, a 0.38% increase from 2023.
- Zymeworks Inc. annual revenue for 2023 was 76.0 M, a 81.57% decrease from 2022.
- Zymeworks Inc. annual revenue for 2022 was 412.5 M.
Zymeworks Inc. (ZYME) — Frequently Asked Questions
Zymeworks Inc. (ZYME) is a publicly traded US company. It has a market capitalization of $1.72B. In fiscal 2025 it reported revenue of $106M and net income of -$81M. Explore ZYME's stock price, financial statements, earnings history, margins and key ratios below.
What is Zymeworks Inc.'s market cap?
Zymeworks Inc. (ZYME) has a market capitalization of $1.72B.
What is the ZYME stock price?
ZYME trades at $22.85 (-1.76% on the day).
How much revenue does Zymeworks Inc. make?
Zymeworks Inc. reported revenue of $106M in fiscal 2025.
Is ZYME profitable?
In fiscal 2025, Zymeworks Inc. reported net income of -$81M.